Search Results - "Magak, Philip"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Case-Control Study of Posttreatment Regression of Urinary Tract Morbidity Among Adults in Schistosoma haematobium-Endemic Communities in Kwale County, Kenya by Magak, Philip, Chang-Cojulun, Alicia, Kadzo, Hilda, Ireri, Edmund, Muchiri, Eric, Kitron, Uriel, King, Charles H

    “…Previous population-based studies have examined treatment impact on Schistosoma-associated urinary tract disease among children, but much less is known about…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Late benefits 10-18 years after drug therapy for infection with Schistosoma haematobium in Kwale District, Coast Province, Kenya by Ouma, John H, King, Charles H, Muchiri, Eric M, Mungai, Peter, Koech, Davy K, Ireri, Edmund, Magak, Philip, Kadzo, Hilda

    “…Late benefits of remote antischistosomal therapy were estimated among long-term residents of an area with high transmission of Schistosoma haematobium…”
    Get more information
    Journal Article
  5. 5

    High prevalence of ectopic kidney in Coast Province, Kenya by Magak, Philip, King, Charles H., Ireri, Edmund, Kadzo, Hilda, Ouma, John H., Muchiri, Eric M.

    Published in Tropical medicine & international health (01-05-2004)
    “…Summary Objective  To establish the prevalence of congenital urinary tract abnormalities in a full population‐based ultrasound survey of an area of coastal…”
    Get full text
    Journal Article
  6. 6

    Population-Based Differences in Schistosoma mansoni- and Hepatitis C-Induced Disease by Blanton, Ronald E., Abdel Salam, Ekram, Kariuki, H. Curtis, Magak, Philip, Silva, Luciano K., Muchiri, Eric M., Thiongo, Fredrick, Abdel-Meghid, Iman E., Butterworth, Anthony E., Reis, Mitermayer G., Ouma, John H.

    Published in The Journal of infectious diseases (01-06-2002)
    “…Two populations with differing histories of Schistosoma mansoni and hepatitis C infection were compared directly for severity of disease and extent of…”
    Get full text
    Journal Article
  7. 7

    Randomized comparison of low-dose versus standard-dose praziquantel therapy in treatment of urinary tract morbidity due to Schistosoma haema tobium infection by King, Charles H, Muchiri, Eric M, Mungai, Peter, Ouma, John H, Kadzo, Hilda, Magak, Philip, Koech, Davy K

    “…At present, anthelmintic therapy with praziquantel at a dose of 40 mg/kg of body weight is the recommended treatment for control of urinary tract morbidity…”
    Get more information
    Journal Article
  8. 8

    Prevalence and Familial Aggregation of Schistosomal Liver Morbidity in Kenya: Evaluation by New Ultrasound Criteria by Kariuki, H. Curtis, Mbugua, Gabriel, Magak, Philip, Bailey, Jeffry A., Muchiri, Eric M., Thiongo, Frederick W., King, Charles H., Butterworth, Anthony E., Ouma, John H., Blanton, Ronald E.

    Published in The Journal of infectious diseases (15-03-2001)
    “…Severe periportal fibrosis is not an inevitable consequence of infection with Schistosoma mansoni Genetic predisposition may be a deciding factor in the…”
    Get full text
    Journal Article
  9. 9

    Indirect assessment of eosinophiluria in urinary schistosomiasis using eosinophil cationic protein (ECP) and eosinophil protein X (EPX) by Reimert, C M, Ouma, J H, Mwanje, M T, Magak, P, Poulsen, L K, Vennervald, B J, Christensen, N O, Kharazmi, A, Bendtzen, K

    Published in Acta tropica (01-06-1993)
    “…The pre- and post-treatment level of eosinophiluria, as measured indirectly by the amount of free or cell bound eosinophil cationic protein (ECP) and…”
    Get more information
    Journal Article